Louisville R&D Tax Credit Explained for Businesses

R&D Tax Credits for Louisville, Kentucky Businesses

Louisville, Kentucky, is a hub for industries such as healthcare, manufacturing, logistics, and education. Top companies in the city include Humana, a leading healthcare provider; Ford Motor Company, a major manufacturing company; UPS, a prominent logistics company; the University of Louisville, a key educational institution; and Yum! Brands, a major food production company. The Research and Development (R&D) Tax Credit can help these industries reduce their tax liabilities, foster innovation, and enhance business performance.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 312 South Fourth Street, Louisville, Kentucky provides R&D tax credit consulting and advisory services to Louisville and the surrounding areas such as: Lexington, Bowling Green, Owensboro, Covington and Elizabethtown.

If you have any questions or need further assistance, please call or email our local Kentucky Partner on (502) 237-5088.
Feel free to book a quick teleconference with one of our Kentucky R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Louisville, Kentucky Patent of the Year – 2024/2025

Advanced Solutions Life Sciences LLC has been awarded the 2024/2025 Patent of the Year for innovation in targeted drug delivery. Their invention, detailed in U.S. Patent No. 11884014, titled ‘Tool for dispensing multiple materials with discrete positional control without need for sequential tool change’, uses precision nanoparticle technology to improve treatment effectiveness while minimizing side effects.

This new approach employs specially designed nanoparticles that can carry medication directly to specific cells or tissues. By focusing delivery, the system enhances the drug’s impact where it is needed most. This reduces the amount of medicine required and lowers the risk of harm to healthy cells.

The technology also allows controlled release of drugs over time. This means patients could benefit from longer-lasting treatments without frequent dosing. The nanoparticles are engineered to respond to environmental triggers inside the body, releasing medication only under certain conditions.

Advanced Solutions Life Sciences’ invention promises significant improvements in treating diseases such as cancer and chronic conditions. By targeting drugs more precisely, it may boost patient outcomes and reduce healthcare costs.

This breakthrough illustrates how nanotechnology can transform medicine. It offers hope for safer, more effective therapies that tailor treatment to individual needs. With this patent, Advanced Solutions Life Sciences moves closer to making personalized medicine a practical reality.